|
|
Line 5: |
Line 5: |
|
| |
|
| == Studies == | | == Studies == |
| | |
| | |
| | ===2021: [https://pubmed.ncbi.nlm.nih.gov/33249498/ Switching to Progressively Reduced Nicotine Content Cigarettes in Smokers With Low Socioeconomic Status: A Double-Blind Randomized Clinical Trial]=== |
| | *Differential dropout and noncompliance indicate some smokers had difficulty transitioning to cigarettes with reduced nicotine. These smokers will benefit from supplemental nicotine in medicinal or noncombustible tobacco products if a nicotine reduction standard is established. Other smokers successfully transitioned to very low nicotine content cigarettes exclusively and substantially reduced their exposure to nicotine. |
|
| |
|
|
| |
|
Line 74: |
Line 78: |
| ===2009: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2573966/ https://pubmed.ncbi.nlm.nih.gov/28214392/]=== | | ===2009: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2573966/ https://pubmed.ncbi.nlm.nih.gov/28214392/]=== |
| *In summary, a toxicological analysis does not indicate that low-nicotine and nicotine-free Quest® cigarettes have less adverse toxicological effects in the laboratory than conventional cigarettes. This should draw the attention of the consumers and policy makers. A more comprehensive evaluation in smokers is expected for these new products. | | *In summary, a toxicological analysis does not indicate that low-nicotine and nicotine-free Quest® cigarettes have less adverse toxicological effects in the laboratory than conventional cigarettes. This should draw the attention of the consumers and policy makers. A more comprehensive evaluation in smokers is expected for these new products. |
|
| |
|
| |
|
| ==Discussion links BLOGs, Articles, Videos, etc== | | ==Discussion links BLOGs, Articles, Videos, etc== |